Melanoma: risk factors and controversies

Karim-Kos HE , de Vries E , Soerjomataram I , Lemmens V , Siesling S , Coebergh JW . Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345–89

Coory M , Baade P , Aitken J , Smithers M , McLeod GR , Ring I . Trends for in situ and invasive melanoma in Queensland, Australia 1982–2002. Cancer Causes Control 2006; 17: 21–7

Whiteman DC , Bray CA , Siskind V , Green AC , Hole DJ , Mackie RM . Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur J Cancer Prev 2008; 17: 243–50

Bliss JM , Ford D , Swerdlow AJ , Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 367–76

Cress RD , Holly EA . Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians and blacks: an analysis of California Cancer Registry data, 1988–93. Cancer Causes Control 1997; 8: 246–52

Rouhani P , Hu S , Kirsner RS . Melanoma in Hispanics and black Americans. Cancer Control 2008; 15: 248–53

Gandini S , Sera F , Cattaruzza MS , Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45–60

Bataille V , Boniol M , de Vries E , A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005; 41: 2141–49

Welch HG , Schwartz LM , Woloshin S . Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000; 283: 2975–8

de Vries E , Boniol M , Doré JF , Coeberg JWW ; Eurocare working group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40: 1045–52

Burton RC , Coates MS , Hersy P , An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765–70

Welch HG , Woloshin S , Schwartz LM . Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005; 331: 481

Gordon L , Youl PH , Elwood M , Diagnosis and management costs of suspicious lesions from a population-based melanoma screening programme. J Med Screen 2007; 14: 98–102

Perez-Gomez B , Aragones S , Gustavsson P , Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br J Dermatol 2008; 158: 766–72

Scoggins CR , Ross MI , Reintgen DS , Gender-related differences in outcome for melanoma patients. Ann Surg 2006; 243: 693–8; discussion 698–700

de Vries E , Nijsten E , Visser O , Superior survival of females among 10,358 Dutch melanoma patients is independent of Breslow thickness, histological type and tumor site. Ann Oncol 2008; 19: 583–9

Bataille V , Kato BS , Falchi M , Nevus size and number are associated with telomere length and represent potential markers of a reduced senescence in vivo. Cancer Epidemiol Biomarkers Prev 2007; 16: 1499–502

Harrison S , MacKie R-M , MacLennan R . Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst 2000; 92: 1436–8

Bataille V , Snieder H , MacGregor AJ , Sasieni P , Spector TD . Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst 2000; 92: 457–63

Wachsmuth RC , Gaut RM , Barrett JH , Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol 2001; 117: 348–52

Bauer J , Büttner P , Wiecker TS , Luther H , Garbe C . Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behaviour. Int J Cancer 2005; 116: 755–61

Gandini S , Sera F , Cattaruzza MS , Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41: 28–44

Chang YM , Newton-Bishop JA , Bishop DT , A pooled analysis of melanocytic naevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer (in press)

Bataille V , Sasieni P , Grulich A , Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer 1998; 78: 8–12

Bataille V , Bishop JA , Sasieni P , Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605–11

Newton Bishop JA and Gruis NA. Genetics: What advice for patients who present with a family history of melanoma? Semin Oncol 2007;34:452–59

Bataille V . Genetic epidemiology of melanoma. Eur J Cancer 2003; 39: 1341–7

Liede A , Karlan BY , Narod SA . Cancer risks for male carriers of germline mutations in BRCA1 and BRCA 2. A review of the literarure. J Clin Oncol 2004; 22: 735–42

Gandini S , Sera F , Cattaruza MF , Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040–59

Raimondi S , Sera F , Gandini S , MCR1R variants, melanoma and red hair colour phenotype: a meta-analsysis. Int J Cancer 2008; 122: 2753–60

Davies H , Bignell GR , Cox C , Mutations of the BRAF gene in human cancer. Nature 2000; 27: 949–54

Whiteman DC , Watt P , Purdie DM , Hughes MC , Hayward NK , Green AC . Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806–12

Wartman D , Weinstock M . Are we overemphasizing sun avoidance in protection from melanoma? Cancer Epidemiol Biomarkers Prev 2008; 17: 469–70

Holick MF . Deficiency of sunlight and Vitamin D. BMJ 2008; 336: 1318–19

Moan J , Porojnicu AC , Dahlback AC , Setlow RB . Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Pro Natl Acad Sci USA 2008; 105: 668–73

Morton DL , Wen DR , Wong JH , Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9

Bieligk SC , Ghossein R , Bhattacharya S , Coit DG . Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999; 6: 232–40

Scolyer RA , Murali R , McCarthy SW , Thompson JF . Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008; 25: 100–11

Thomas JM , A'Hern RP , Grichnik JM , Sentinel-node biopsy in melanoma. N Engl J Med 2007; 356: 418–21

Balch CM , Buzaid AC , Soong SJ , Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635–48

Morton DL , Thompson JF , Cochran AJ , Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307–17

Pizarro A . [Why does sentinel-node lymph node biopsy not increase survival in patients with melanoma?] Actas Dermosifiliogr 2008; 99: 323–30

Cook MG , Di Palma S . Pathology of sentinel lymph nodes for melanoma. J Clin Pathol 2008; 61: 897–902

Medalie N , Ackerman AB . Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastized to a lymph node and therefore should be abandoned now. Br J Dermatol 2004; 151: 298–307